Design, Synthesis, Characterisation and Biological Study of Pyrimidine Based Heterocycles
Clicks: 1
ID: 309142
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #111 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
A series of novel 4-(2-amino-6-(substituted phenyl)pyrimidine-4-yl)-2,6-dibromobenzene-1,3-diol, were synthesized from different substituted 2,3-dibromo-1-(3,5-dibromo-2,4-dihydroxyphenyl)-3-(substitutedphenyl)propane-1-one and guanidine hydrochloride were dissolved in ethanol. Double the quantity of sodium hydroxide was dissolved in minimum amount of water and added to reaction mixture. After 6Hrs. reflux, it was poured into 250 ml of water and recrystalized the structures of the compounds were elucidated by elemental and spectral (IR, 1H NMR,) analysis. The synthesized compounds were checked for biological evaluation i.e. antimicrobial study.
| Reference Key |
imported_1761926380_6904dcec02a0f
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | O. K. Kapse |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2025 |
| DOI |
10.62896/ijpdd.2.7.05
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.